ReviewTherapeutic advances in reproductive health

Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review.

Caroline Ingold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.